The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Bruce C. Baguley

The University of Auckland

Auckland Cancer Society Research Centre

Faculty of Medical and Health Sciences

Private Bag 92019

New Zealand

[email]@auckland.ac.nz

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • The University of Auckland, Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, Private Bag 92019, New Zealand. 1998 - 2010
  • Cancer Research Laboratory, University of Auckland School of Medicine, New Zealand. 1997 - 2010

References

  1. Temporal aspects of the action of ASA404 (vadimezan; DMXAA). Baguley, B.C., Siemann, D.W. Expert. Opin. Investig. Drugs (2010) [Pubmed]
  2. ASA404: a tumor vascular-disrupting agent with broad potential for cancer therapy. Baguley, B.C., McKeage, M.J. Future. Oncol (2010) [Pubmed]
  3. Multidrug resistance in cancer. Baguley, B.C. Methods Mol. Biol. (2010) [Pubmed]
  4. Tumor stem cell niches: a new functional framework for the action of anticancer drugs. Baguley, B.C. Recent. Patents. Anti-cancer. Drug. Discovery (2006) [Pubmed]
  5. Do negative feedback oscillations drive variations in the length of the tumor cell division cycle?. Baguley, B.C., Marshall, E. Oncol. Res. (2005) [Pubmed]
  6. In vitro modelling of human tumour behaviour in drug discovery programmes. Baguley, B.C., Marshall, E.S. Eur. J. Cancer (2004) [Pubmed]
  7. Antivascular therapy of cancer: DMXAA. Baguley, B.C. Lancet Oncol. (2003) [Pubmed]
  8. Mechanisms of action of DNA intercalating acridine-based drugs: how important are contributions from electron transfer and oxidative stress?. Baguley, B.C., Wakelin, L.P., Jacintho, J.D., Kovacic, P. Curr. Med. Chem. (2003) [Pubmed]
  9. Novel strategies for overcoming multidrug resistance in cancer. Baguley, B.C. BioDrugs (2002) [Pubmed]
  10. Potential of DMXAA combination therapy for solid tumors. Baguley, B.C., Wilson, W.R. Expert. Rev. Anticancer. Ther (2002) [Pubmed]
  11. DMXAA: an antivascular agent with multiple host responses. Baguley, B.C., Ching, L.M. Int. J. Radiat. Oncol. Biol. Phys. (2002) [Pubmed]
  12. Small-molecule cytokine inducers causing tumor necrosis. Baguley, B.C. Curr. Opin. Investig. Drugs (2001) [Pubmed]
  13. Short-term cultures of clinical tumor material: potential contributions to oncology research. Baguley, B.C., Marshall, E.S., Finlay, G.J. Oncol. Res. (1999) [Pubmed]
  14. Mutagenic properties of topoisomerase-targeted drugs. Baguley, B.C., Ferguson, L.R. Biochim. Biophys. Acta (1998) [Pubmed]
  15. Increased plasma serotonin following treatment with flavone-8-acetic acid, 5,6-dimethylxanthenone-4-acetic acid, vinblastine, and colchicine: relation to vascular effects. Baguley, B.C., Zhuang, L., Kestell, P. Oncol. Res. (1997) [Pubmed]
 
WikiGenes - Universities